Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.24% | -1.28% | +0.89% |
04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.89% | 42.03B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Says European Commission Granted Marketing Approval for Cytomegalovirus Infection Treatment